Associated Papers
Exploring Co-occurring POLE Exonuclease and Non-exonuclease Domain Mutations and Their Impact on Tumor Mutagenicity.
Shah SM et al.
Cancer Research Communications, 2024
38282550 (PubMed )
Supplement: crc-23-0312-s02.xlsx › Fig3A_CRC_data
Clinicopathologic Characteristics and Outcomes for Patients With KRAS G12D-Mutant NSCLC.
Cooper AJ et al.
Jto Clinical and Research Reports, 2022
36118132 (PubMed )
Supplement: mmc2.docx
DeteX: A highly accurate software for detecting SNV and InDel in single and paired NGS data in cancer research.
Cui Y et al.
Frontiers in Genetics, 2022
36685970 (PubMed )
Supplement: Table5.xlsx › Sheet1
Landscape of IDH1/2 mutations in Chinese patients with solid tumors: A pan-cancer analysis.
Shen D et al.
Molecular Genetics & Genomic Medicine, 2021
Characterization of colibactin-associated mutational signature in an Asian oral squamous cell carcinoma and in other mucosal tumor types.
Boot A et al.
Genome Research, 2020
32661091 (PubMed )
Supplement: supp_gr.255620.119_Supplemental_Table_S2.xlsx › Sheet1
Genomic characterization of high-recurrence risk papillary thyroid carcinoma in a southern Chinese population.
Li M et al.
Diagnostic Pathology, 2020
32393293 (PubMed )
Supplement: 13000_2020_962_MOESM2_ESM.xlsx › Sheet1
Does breast carcinoma belong to the Lynch syndrome tumor spectrum? - Somatic mutational profiles vs. ovarian and colorectal carcinomas.
Porkka NK et al.
Oncotarget, 2020
32292574 (PubMed )
Supplement: oncotarget-11-1244-s005.xlsx › Sheet1
Prevalence and detection of low-allele-fraction variants in clinical cancer samples.
Shin HT et al.
Nature Communications, 2017
29123093 (PubMed )
Supplement: 41467_2017_1470_MOESM1_ESM.pdf
Integrated genomic characterization of oesophageal carcinoma.
Unknown Author
Nature, 2017
28052061 (PubMed )
Supplement: NIHMS905030-supplement-Supplemental_Data.pdf
Ordering of mutations in acute myeloid leukemia with partial tandem duplication of MLL (MLL-PTD).
Sun QY et al.
Leukemia, 2017
27389053 (PubMed )
Supplement: leu2016160x1.doc
A high frequency of activating extracellular domain ERBB2 (HER2) mutation in micropapillary urothelial carcinoma.
Ross JS et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research, 2014
Select a paper to view details